跳至主要内容
临床试验/NCT03152773
NCT03152773终止不适用

Heart Catheterization Using Magnetic Resonance Imaging (MRI) Fluoroscopy and Passive Guidewires

National Heart, Lung, and Blood Institute (NHLBI)1 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2017年8月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
22
试验地点
1
主要终点
The principal objective of this protocol is to test the safety and feasibility of MRI fluoroscopy catheter navigation using 0.035 guidewires during left and right heart catheterization guided by low-SAR MRI pulse sequences

研究概览

简要总结

Background:

A heart catheterization is a diagnostic heart procedure used to measure pressures and take pictures of the blood flow through the heart chambers. Magnetic resonance imaging (MRI) fluoroscopy shows continuous pictures of the heart chambers that doctors can watch while they work. Researchers want to test this procedure with catheterization tools routinely used in x-ray catheterization called guidewires. Guidewires will help move the heart catheter through the different heart chambers. Guidewires are usually considered unsafe during MRI because MRI can cause a guidewire to heat while inside the blood vessels and heart. Researchers are testing special low energy MRI settings that allow certain guidewires to be used during MRI catheterization without heating. Using these guidewires during MRI may help to decrease the amount of time you are in the MRI scanner, and the overall time the MRI catheterization procedure takes.

Objectives:

To test if certain MRI settings make it safe to use a guidewire during MRI fluoroscopy.

Eligibility:

Adults 18 and older whose doctors have recommended right heart catheterization.

Design:

Researchers will screen participants by reviewing their lab results and questionnaire answers.

Participants may give 4 blood samples.

Participants will be sedated. They will have a tube (catheter) placed in the groin, arm, or neck if they don t already have one.

Patches on the skin will monitor heart rhythm. Special antennas, covered in pads, will be placed against the body.

Participants will lie flat on a table that slides in and out of the MRI scanner as it makes pictures. Participants will get earplugs for the loud knocking noise. They can talk on an intercom. They will be inside the scanner for up to 2 hours. They can ask to stop at any time.

During a heart catheterization, catheters will be inserted through the tubes already in place. The catheters are guided by MRI fluoroscopy into the chambers of the heart and vessels. The guidewire will help position the catheter.

详细描述

Heart catheterization is a minimally invasive procedure to measure pressure into specific heart cavities. Heart catheterization usually uses X-ray guidance, which involves radiation exposure, and which fails to visualize soft tissue. For several years, real-time magnetic resonance imaging (MRI) fluoroscopy has been the standard technique to guide right heart catheterization at the NIH clinical center.

Guidewires are standard tools used to steer catheters through the body and heart. Guidewires have not been used during MRI fluoroscopy catheterization because of the risk of heating. We have developed MRI techniques that do not risk heating using specific commercial guidewires. In this protocol we will use this new low-energy real-time MRI fluoroscopy technique to enable use of guidewires during otherwise standard MRI catheterization of the right side of the heart through veins, and of the left side of the heart through the aorta.

In the second phase of the protocol, we will begin performing systematic MRI guidewire heart catheterization without X-ray whenever possible. We will assess the heart s response to hemodynamic provocation during MRI catheterization tailored to the patient s problem. We will use this protocol to further refine the technique.

This will enable future testing of devices for adult and pediatric MRI-fluoroscopy catheterization, which may lead to new non-surgical treatments of cardiovascular disease.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • INCLUSION CRITERIA:
  • Age greater than or equal to 18 years old
  • Undergoing medically necessary diagnostic or interventional right cardiovascular catheterization, alone or in combination with a left cardiovascular catheterization

排除标准

  • Cardiovascular instability including ongoing acute myocardial infarction, refractory angina or ischemia, and decompensated congestive heart failure.
  • Women who are pregnant or nursing
  • Unable to undergo magnetic resonance imaging
  • Cerebral aneurysm clip
  • Neural stimulator (e.g. TENS-Unit)
  • Any type of ear implant
  • Ocular foreign body (e.g. metal shavings)
  • Metal shrapnel or bullet.
  • Any implanted device (e.g. insulin pump, drug infusion device), unless it is labeled safe for MRI
  • EXCLUSION CRITERIA FOR GADOLINIUM-BASED CONTRAST AGENTS:
  • Renal excretory dysfunction, estimated glomerular filtration rate < 30 mL/min/1.73m2 body surface area according to the Modification of Diet in Renal Disease criteria
  • Glomerular filtration rate will be estimated using the CKD-EPI equation:
  • eGFR = 141 x (minimum of (S(Cr)/k, 1)^alpha x (maximum of (S(Cr) /k, 1))^-1.209 x 0.993^Age x 1.018 (if female) x 1.159 (if black)
  • S(Cr) = serum creatinine
  • alpha = -0.329 for females and -0.411 for males
  • k = 0.7 for females and 0.9 for males
  • Subjects meeting this exclusion criterion may still be included in the study but may not be exposed to gadolinium-based contrast agents.
  • Exclusion criteria for ferumoxytol:
  • Allergy to ferumoxytol or to mannitol excipient
  • Does not wish to be exposed to ferumoxytol
  • Exclusion criteria for MRI left heart catheterization:
  • Severe aortic valve stenosis

研究组 & 干预措施

Participants Undergoing Clinically Indicated Cardiac Catheterization

Experimental

Participants undergoing clinically indicated right heart catheterization will undergo MRI-guided cardiac guidewire catheterization. The procedure will involve left and right heart guidewire catheterization using real-time MRI fluoroscopy in human research participants who are already undergoing medically necessary cardiac catheterization.

干预措施: MRI Heart guidewire catheterization (Diagnostic Test)

结局指标

主要结局

The principal objective of this protocol is to test the safety and feasibility of MRI fluoroscopy catheter navigation using 0.035 guidewires during left and right heart catheterization guided by low-SAR MRI pulse sequences

时间窗: 2 hours

Acquisition of hemodynamic and saturation data from targeted chambers and vessels.

Number of Participants With Procedure-Related Adverse Events During Low-SAR MRI-Guided Catheterization

时间窗: During procedure through discharge, up to 4 hours after the procedure

Number of participants with any procedure-related adverse event during MRI-guided cardiac catheterization using passive MRI-compatible catheters and the specified guidewire under defined low-SAR conditions using Common Terminology Criteria for Adverse Events (CTCAE) grading. Events included clinically significant arrhythmia, hemodynamic instability requiring treatment, vascular injury, cardiac perforation/tamponade, device-related heating or burn, or other intervention-related complication. The CTCAE employs a 5-point scale to standardize the grading of adverse events from mild to fatal: * Grade 1 (Mild): Asymptomatic or mild symptoms; no intervention required. * Grade 2 (Moderate): Local/noninvasive intervention needed; limits instrumental ADL. * Grade 3 (Severe): Severe/medically significant; hospitalization or prolongation; limits self-care ADL. * Grade 4 (Life-threatening): Urgent intervention required. * Grade 5 (Fatal): Death related to the adverse event

次要结局

  • Additional objectives are to test and enhanced MRI as an adjunct to routine hemodynamic cardiac catheterization(2 hours)
  • Number of Participants Who Completed the MRI-guided Portion of Cardiac Catheterization Without Life-threatening Hemodynamic Instability(From start of MRI-guided catheterization through completion of the procedure)

研究者

申办方类型
Nih
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验